These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17572707)

  • 1. Donor-origin cell engraftment after intraosseous or intravenous bone marrow transplantation in a rat model.
    Klimczak A; Unal S; Jankowska A; Coburn C; Siemionow M
    Bone Marrow Transplant; 2007 Aug; 40(4):373-80. PubMed ID: 17572707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
    Siemionow MZ; Klimczak A; Unal S
    Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II.
    Klimczak A; Agaoglu G; Carnevale KA; Siemionow M
    Ann Plast Surg; 2006 Oct; 57(4):422-30. PubMed ID: 16998336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients.
    Kulahci Y; Klimczak A; Madajka M; Altuntas S; Siemionow M
    Transplantation; 2010 Oct; 90(8):843-52. PubMed ID: 20697324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
    Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap.
    Nasir S; Klimczak A; Sonmez E; Bozkurt M; Gibson S; Siemionow M
    Transpl Int; 2010 Jan; 23(1):90-100. PubMed ID: 19686290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model.
    Kuo YR; Goto S; Shih HS; Wang FS; Lin CC; Wang CT; Huang EY; Chen CL; Wei FC; Zheng XX; Lee WP
    Transplantation; 2009 Jun; 87(12):1769-77. PubMed ID: 19543052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of donor-specific chimerism and tolerance in composite tissue allografts under alphabeta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols.
    Ozer K; Izycki D; Zielinski M; Siemionow M
    Microsurgery; 2004; 24(3):248-54. PubMed ID: 15160385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new method of bone marrow transplantation leads to extension of skin allograft survival.
    Siemionow M; Ozer K; Izycki D; Unsal M; Klimczak A
    Transplant Proc; 2005 Jun; 37(5):2309-14. PubMed ID: 15964406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells.
    Fukui J; Inaba M; Ueda Y; Miyake T; Hosaka N; Kwon AH; Sakaguchi Y; Tsuda M; Omae M; Kamiyama Y; Ikehara S
    Stem Cells; 2007 Jun; 25(6):1595-601. PubMed ID: 17446564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
    Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
    J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor bone marrow in laryngeal transplantation: results of a rat study.
    Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M
    Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reversed paradigm of chimerism induction: Donor conditioning with recipient-derived bone marrow cells as a novel approach for tolerance induction in vascularized composite allotransplantation.
    Siemionow M; Rampazzo A; Gharb BB; Cwykiel J; Klimczak A; Madajka M; Nasir S; Bozkurt M
    Microsurgery; 2016 Nov; 36(8):676-683. PubMed ID: 26990895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose.
    Koh CY; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2005 Apr; 11(4):252-9. PubMed ID: 15812390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.